Clinical Features and Linked MEchanisms in Acute Risk-free AMI

Launched by BEIJING ANZHEN HOSPITAL · Nov 29, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the characteristics and causes of acute myocardial infarction (AMI), commonly known as a heart attack, in patients who do not have the usual risk factors like high blood pressure, diabetes, or a history of smoking. The researchers want to learn more about why these patients experience heart attacks and identify any new potential risk factors that could help improve how we diagnose and treat AMI.

To participate in this study, individuals need to be at least 18 years old and have been diagnosed with a heart attack based on standard medical tests. However, they should not have any of the common risk factors mentioned earlier. Participants will undergo various tests and evaluations to gather important information about their heart health. It’s important to note that this trial is not yet recruiting participants, so if you or someone you know is interested, keep an eye out for updates!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with acute myocardial infarction (AMI) based on standard clinical criteria (e.g., troponin elevation, ischemic symptoms, or imaging evidence of myocardial injury).
• • Absence of traditional cardiovascular risk factors, including hypertension, diabetes, dyslipidemia, smoking, or obesity (BMI \< 30 kg/m²).
• • Aged 18 years or older. Willing and able to provide informed consent.
• Exclusion Criteria:
• • Presence of any traditional cardiovascular risk factors as defined above. History of known congenital or structural heart disease. Severe systemic diseases that could independently contribute to AMI (e.g., severe infection, malignancy, or autoimmune disorders).
• • Recent history of major surgery or trauma within the last 3 months. Pregnancy or lactation. Inability to provide informed consent due to cognitive impairment or other reasons.
• • Participation in another interventional clinical trial that might interfere with study outcomes.